Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
UBS
US Department of Justice
Cantor Fitzgerald
Colorcon
Chinese Patent Office
Boehringer Ingelheim
Deloitte
Teva

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,661,491

« Back to Dashboard

Summary for Patent: 4,661,491
Title: Alfuzosine compositions and use
Abstract:A method for treating humans or non-human animals for dysuria comprising administering an effective non-toxic amount of alfuzosine or a pharmaceutically acceptable salt thereof to a human or non-human animal suffering dysuria.
Inventor(s): Regnier; Francois (Nancy, FR)
Assignee: Synthelabo (Paris, FR)
Application Number:06/867,031
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 4,661,491

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,661,491

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France85 07950May 28, 1985

International Patents Family Members for US Patent 4,661,491

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 5795186 ➤ Try a Free Trial
Australia 586684 ➤ Try a Free Trial
Canada 1261755 ➤ Try a Free Trial
Germany 3683318 ➤ Try a Free Trial
Denmark 168029 ➤ Try a Free Trial
Denmark 246586 ➤ Try a Free Trial
European Patent Office 0204597 ➤ Try a Free Trial
France 2582513 ➤ Try a Free Trial
Hungary T46221 ➤ Try a Free Trial
Ireland 58595 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Harvard Business School
Healthtrust
Moodys
Baxter
Medtronic
US Department of Justice
Federal Trade Commission
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot